International Journal of Medical Laboratory Research (IJMLR)

IS RESISTANCE TO ETHIONAMIDE AN EXTRAPOLATION OF OTHER FIRST AND SECOND LINE ANTI- TUBERCULOSIS DRUGS?

 

Rajagopalan Lakshmi*, Vanaja Kumar, Ranjani Ramachandran, C Ponnuraja, P Venkatesan

​

ABSTRACT: Drug Susceptibility profile of ethionamide and other first and second line anti tuberculosis drugs revealed no significant association, indicating the resistance towards ethionamide is the result of individual effect and not an extrapolation of other drug resistant phenotypes.

KEY WORDS: Mycobacterium tuberculosis; MIC method; Ethionamide; Multi drug resistance

​

REFERENCES:

 

1. Rattan A., Kalia A., Ahmad N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. 1998;4(2):195-209

2. Ramachandran R., Nalini S., Chandrasekar V., Dave P. V., Sanghvi A. S., Wares F., et al. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis 2009;13(9):1154-1160

3. Banerjee A., Dubnau E., Quemard A., et al. A, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994;263:227-230

4. Larsen M. H., Vilcheze C., Kremer L., et al.Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis. Mol Microbiol 2002;46:453-466

5. Standard Operating Procedure for Mycobacteriology Laboratory. Department of Bacteriology, Tuberculosis Research Centre (ICMR), Chetput, Chennai- 600 031, India. Version 1.1, November 2010

6. Quemard A., Laneelle G., Lacave C. Mycolic acid synthesis: a target for ethionamide in mycobacteria? Antimicrob AgentsChemotherapy 1992;36:1316-1321

7. Morlock G. P., Metchock B., Sikes D., Crawford J. T., Cooksey R. C. A, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrobial Agents and Chemotherapy 2003;47(12):3799-3805

8. Xu-De Wang, Jing Gu, Ting Wang, Li-Jun Bi, Zhi-Ping Zhang, Zong-Qiang Cui, et al. Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation. Mol Microbiol 2011;82(6):1375–1391

9. Xu X., Vilchèze C., Av-Gay Y., Gómez-Velasco A., Jacobs W. R Jr. Precise null deletion mutations of the mycothiol synthesis genes reveal their role in isoniazid and ethionamide resistance in Mycobacterium smegmatis.  Antimicrob Agents Chemother 2011;55(7):3133-3139.